63 related articles for article (PubMed ID: 28150071)
41. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.
Moss SF; Lee JW; Sabo E; Rubin AK; Rommel J; Westley BR; May FE; Gao J; Meitner PA; Tavares R; Resnick MB
Clin Cancer Res; 2008 Jul; 14(13):4161-7. PubMed ID: 18593995
[TBL] [Abstract][Full Text] [Related]
42. Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins.
Kouznetsova I; Laubinger W; Kalbacher H; Kalinski T; Meyer F; Roessner A; Hoffmann W
Cell Physiol Biochem; 2007; 20(6):899-908. PubMed ID: 17982272
[TBL] [Abstract][Full Text] [Related]
43. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
Walker DG; Link J; Lue LF; Dalsing-Hernandez JE; Boyes BE
J Leukoc Biol; 2006 Mar; 79(3):596-610. PubMed ID: 16365156
[TBL] [Abstract][Full Text] [Related]
44. Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C.
Westley BR; Griffin SM; May FE
Biochemistry; 2005 Jun; 44(22):7967-75. PubMed ID: 15924415
[TBL] [Abstract][Full Text] [Related]
45. Trefoil factors: initiators of mucosal healing.
Taupin D; Podolsky DK
Nat Rev Mol Cell Biol; 2003 Sep; 4(9):721-32. PubMed ID: 14506475
[TBL] [Abstract][Full Text] [Related]
46. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.
LAUREN P
Acta Pathol Microbiol Scand; 1965; 64():31-49. PubMed ID: 14320675
[No Abstract] [Full Text] [Related]
47. Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.
Carvalho R; Kayademir T; Soares P; Canedo P; Sousa S; Oliveira C; Leistenschneider P; Seruca R; Gött P; Blin N; Carneiro F; Machado JC
Lab Invest; 2002 Oct; 82(10):1319-26. PubMed ID: 12379766
[TBL] [Abstract][Full Text] [Related]
48. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
49. The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis.
Bossenmeyer-Pourié C; Kannan R; Ribieras S; Wendling C; Stoll I; Thim L; Tomasetto C; Rio MC
J Cell Biol; 2002 May; 157(5):761-70. PubMed ID: 12034770
[TBL] [Abstract][Full Text] [Related]
50. Somatic mutations of the trefoil factor family 1 gene in gastric cancer.
Park WS; Oh RR; Park JY; Lee JH; Shin MS; Kim HS; Lee HK; Kim YS; Kim SY; Lee SH; Yoo NJ; Lee JY
Gastroenterology; 2000 Sep; 119(3):691-8. PubMed ID: 10982763
[TBL] [Abstract][Full Text] [Related]
51. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis.
Fujimoto J; Yasui W; Tahara H; Tahara E; Kudo Y; Yokozaki H; Tahara E
Cancer Lett; 2000 Feb; 149(1-2):125-34. PubMed ID: 10737716
[TBL] [Abstract][Full Text] [Related]
52. The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.
Newton JL; Allen A; Westley BR; May FE
Gut; 2000 Mar; 46(3):312-20. PubMed ID: 10673290
[TBL] [Abstract][Full Text] [Related]
53. The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS.
Calnan DP; Westley BR; May FE; Floyd DN; Marchbank T; Playford RJ
J Pathol; 1999 Jul; 188(3):312-7. PubMed ID: 10419601
[TBL] [Abstract][Full Text] [Related]
54. Trefoil peptides.
Wong WM; Poulsom R; Wright NA
Gut; 1999 Jun; 44(6):890-5. PubMed ID: 10323896
[No Abstract] [Full Text] [Related]
55. Tissue microarrays for high-throughput molecular profiling of tumor specimens.
Kononen J; Bubendorf L; Kallioniemi A; Bärlund M; Schraml P; Leighton S; Torhorst J; Mihatsch MJ; Sauter G; Kallioniemi OP
Nat Med; 1998 Jul; 4(7):844-7. PubMed ID: 9662379
[TBL] [Abstract][Full Text] [Related]
56. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein.
Lefebvre O; Chenard MP; Masson R; Linares J; Dierich A; LeMeur M; Wendling C; Tomasetto C; Chambon P; Rio MC
Science; 1996 Oct; 274(5285):259-62. PubMed ID: 8824193
[TBL] [Abstract][Full Text] [Related]
57. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.
Babyatsky MW; deBeaumont M; Thim L; Podolsky DK
Gastroenterology; 1996 Feb; 110(2):489-97. PubMed ID: 8566596
[TBL] [Abstract][Full Text] [Related]
58. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.
Wright NA; Poulsom R; Stamp G; Van Noorden S; Sarraf C; Elia G; Ahnen D; Jeffery R; Longcroft J; Pike C
Gastroenterology; 1993 Jan; 104(1):12-20. PubMed ID: 8419234
[TBL] [Abstract][Full Text] [Related]
59. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7.
Brown AM; Jeltsch JM; Roberts M; Chambon P
Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6344-8. PubMed ID: 6593703
[TBL] [Abstract][Full Text] [Related]
60. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7.
Jakowlew SB; Breathnach R; Jeltsch JM; Masiakowski P; Chambon P
Nucleic Acids Res; 1984 Mar; 12(6):2861-78. PubMed ID: 6324130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
